283 related articles for article (PubMed ID: 11962246)
1. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.
Barber MD; Fearon KC; Tisdale MJ; McMillan DC; Ross JA
Nutr Cancer; 2001; 40(2):118-24. PubMed ID: 11962246
[TBL] [Abstract][Full Text] [Related]
2. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.
Barber MD; McMillan DC; Preston T; Ross JA; Fearon KC
Clin Sci (Lond); 2000 Apr; 98(4):389-99. PubMed ID: 10731472
[TBL] [Abstract][Full Text] [Related]
3. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.
Barber MD; Ross JA; Voss AC; Tisdale MJ; Fearon KC
Br J Cancer; 1999 Sep; 81(1):80-6. PubMed ID: 10487616
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients.
Barber MD; Preston T; McMillan DC; Slater C; Ross JA; Fearon KC
Clin Sci (Lond); 2004 Apr; 106(4):359-64. PubMed ID: 14624668
[TBL] [Abstract][Full Text] [Related]
5. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
Cerchietti LC; Navigante AH; Castro MA
Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
[TBL] [Abstract][Full Text] [Related]
6. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study.
Persson C; Glimelius B; Rönnelid J; Nygren P
Nutrition; 2005 Feb; 21(2):170-8. PubMed ID: 15723745
[TBL] [Abstract][Full Text] [Related]
7. Leucine kinetics in patients with benign disease, non-weight-losing cancer, and cancer cachexia: studies at the whole-body and tissue level and the response to nutritional support.
Shaw JH; Humberstone DA; Douglas RG; Koea J
Surgery; 1991 Jan; 109(1):37-50. PubMed ID: 1984636
[TBL] [Abstract][Full Text] [Related]
8. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
[TBL] [Abstract][Full Text] [Related]
9. Effect of fish oil supplementation for two generations on changes of lymphocyte function induced by Walker 256 cancer cachexia in rats.
Folador A; de Lima-Salgado TM; Hirabara SM; Aikawa J; Yamazaki RK; Martins EF; de Oliveira HH; Pizatto N; Kanunfre CC; Peres CM; Fernandes LC; Curi R
Nutr Cancer; 2009; 61(5):670-9. PubMed ID: 19838941
[TBL] [Abstract][Full Text] [Related]
10. The 'cancer cachectic factor'.
Tisdale MJ
Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.
Wigmore SJ; Barber MD; Ross JA; Tisdale MJ; Fearon KC
Nutr Cancer; 2000; 36(2):177-84. PubMed ID: 10890028
[TBL] [Abstract][Full Text] [Related]
12. Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients.
Silva Jde A; Trindade EB; Fabre ME; Menegotto VM; Gevaerd S; Buss Zda S; Frode TS
Nutr Cancer; 2012; 64(2):267-73. PubMed ID: 22295891
[TBL] [Abstract][Full Text] [Related]
13. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state.
Jellema A; Plat J; Mensink RP
Eur J Clin Invest; 2004 Nov; 34(11):766-73. PubMed ID: 15530150
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy evaluation of an oral powder supplement enriched with eicosapentaenoic acid in cancer patients].
Gómez-Candela C; Villarino Sanz M; Horrisberger A; Loria Kohen V; Bermejo LM; Zamora Auñón P
Nutr Hosp; 2011; 26(6):1385-93. PubMed ID: 22411387
[TBL] [Abstract][Full Text] [Related]
15. Effects of dietary supplementation with fish oil on in vivo production of inflammatory mediators in clinically normal dogs.
LeBlanc CJ; Horohov DW; Bauer JE; Hosgood G; Mauldin GE
Am J Vet Res; 2008 Apr; 69(4):486-93. PubMed ID: 18380580
[TBL] [Abstract][Full Text] [Related]
16. Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer.
Barber MD; Ross JA; Preston T; Shenkin A; Fearon KC
J Nutr; 1999 Jun; 129(6):1120-5. PubMed ID: 10356075
[TBL] [Abstract][Full Text] [Related]
17. [Effects of lactone I from Atractylodes macrocephala Koidz on cytokines and proteolysis-inducing factors in cachectic cancer patients].
Liu Y; Ye F; Qiu GQ; Zhang M; Wang R; He QY; Cai Y
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1308-11. PubMed ID: 16234118
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.
Burns CP; Halabi S; Clamon G; Kaplan E; Hohl RJ; Atkins JN; Schwartz MA; Wagner BA; Paskett E
Cancer; 2004 Jul; 101(2):370-8. PubMed ID: 15241836
[TBL] [Abstract][Full Text] [Related]
19. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473.
Burns CP; Halabi S; Clamon GH; Hars V; Wagner BA; Hohl RJ; Lester E; Kirshner JJ; Vinciguerra V; Paskett E
Clin Cancer Res; 1999 Dec; 5(12):3942-7. PubMed ID: 10632323
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects.
Wallace FA; Miles EA; Calder PC
Br J Nutr; 2003 May; 89(5):679-89. PubMed ID: 12720588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
